You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer

Article metrics

Article menu
Basic tumor immunology
Original research
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer

 

Online download statistics by month:

Online download statistics by month: January 2022 to July 2025

AbstractFullPdf
Jan 2022456476226
Feb 202221021152
Mar 202216917560
Apr 202215115537
May 202211511736
Jun 202213614227
Jul 202212512935
Aug 202213713719
Sep 202211311525
Oct 202210010325
Nov 2022919123
Dec 2022747416
Jan 2023606021
Feb 2023666614
Mar 2023424327
Apr 2023454522
May 2023585811
Jun 2023393914
Jul 2023414119
Aug 2023545418
Sep 2023383910
Oct 2023242415
Nov 2023313214
Dec 2023414211
Jan 2024292919
Feb 2024353515
Mar 2024555549
Apr 2024494918
May 2024454616
Jun 2024535219
Jul 2024394019
Aug 2024403717
Sep 2024495126
Oct 2024575726
Nov 2024505119
Dec 2024353711
Jan 2025515120
Feb 2025898916
Mar 2025343420
Apr 2025535331
May 2025343423
Jun 2025303122
Jul 2025110
Total324433001163